title: The Antidote Is Finally Here! Idarucizumab, A Specific Reversal Agent for the Anticoagulant Effects of Dabigatran.
authors: Author Affiliation: Nurse Researcher, Center for Nursing Excellence, Premier Health-Miami Valley Hospital, Dayton, Ohio.
authors: Patricia Anne
authors: PA
authors: O'Malley
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000925:Anticoagulants / Q000009:adverse effects; D000931:Antidotes / Q000627:therapeutic use*; D000069604:Dabigatran / Q000009:adverse effects; D017277:Drug Approval; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000925:Anticoagulants; D000931:Antidotes; C000594745:idarucizumab; D000069604:Dabigatran